Vasiliki Triantafillou
Alan D. Workman
Michael A. Kohanski1- 1Department of Otorhinolaryngology–Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, United States
- 2Department of Otorhinolaryngology-Head and Neck Surgery, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, United States
Bitter (T2R) and sweet taste (T1R) receptors have emerged as regulators of upper airway immune responses. Genetic variation of these taste receptors additionally confers susceptibility to infection and has been implicated in severity of disease in chronic rhinosinusitis (CRS). Ongoing taste receptor research has identified a variety of biologically active compounds that activate T1R and T2R receptors, increasing our understanding of not only additional receptor isoforms and their function but also how receptor function may contribute to the pathophysiology of CRS. This review will discuss the function of taste receptors in mediating airway immunity with a focus on recently described modulators of receptor function and directions for future research into the potential role of genotypic and phenotypic receptor variation as a predictor of airway disease and response to therapy.
Introduction
The upper respiratory tract depends upon several mechanisms to detect and then mount defenses against pathogenic bacteria to prevent colonization and infection. Failure of these mechanisms is observed in many upper respiratory diseases, including chronic rhinosinusitis (CRS). While the etiology of CRS is multifactorial, defective mucociliary clearance resulting in the stasis of sinonasal secretions is a common final pathophysiologic contributor to the disease. Leading to ultimate mucociliary dysfunction are varied environmental and genetic factors (Antunes et al., 2009).
CRS affects approximately 16% of Americans with costs exceeding $8 billion annually (Bhattacharyya, 2011; Orlandi et al., 2016; Rudmik, 2017). Individuals with CRS often require prolonged antibiotic treatment, with CRS accounting for 20% of adult antibiotic prescriptions (Bhattacharyya and Kepnes, 2008). Patients not only report poor quality of life (QOL) on sinus-specific scales (Gliklich and Metson, 1995; Hopkins et al., 2009), but also more severe impairment in general quality of life (QOL) scores than patients suffering from chronic respiratory or heart diseases (Soler et al., 2011). Despite this enormous economic, quality of life, and public health burden, the pathophysiological mechanisms underlying the disease, including the genetic predisposition to the development of CRS (Cohen et al., 2006; Hamilos, 2007; Fokkens et al., 2012; Adappa et al., 2013; Lee and Cohen, 2013; Cohen, 2017), are just beginning to be elucidated.
Studies in recent years have described an emerging role for bitter and sweet taste receptors as upper airway sentinels that sense secreted bacterial products and subsequently regulate innate immune responses (Tizzano et al., 2010; Lee et al., 2012, 2014). Furthermore, polymorphisms in these receptors contribute not only to individual preferences in taste (Hayes et al., 2011), but also correlate with CRS disease severity (Lee et al., 2012; Adappa et al., 2016b; Carey et al., 2017). This review will discuss the function of taste receptors in mediating airway immunity with a focus on modulators of receptor function and the clinical implications of genotypic and phenotypic variations as predictors of airway disease and response to therapy.
Mechanisms of Sinonasal Innate Immunity
The sinonasal cavity is the respiratory system's first line of defense against the continuous insult of inhaled pathogens and particulate debris. The sinonasal tract consists of goblet cells which produce a mucus gel and ciliated cells that function not only as a physical epithelial cell barrier but also in mucus transport, clearing debris and microbes trapped in mucus secretions through the process of mucociliary clearance (MCC) (Sleigh et al., 1988). MCC requires coordinated ciliary beating to propel mucus toward the oropharynx where it is swallowed or expectorated and is influenced by mucus viscosity (Liu et al., 2014) as well as mechanical and biological stimuli that accelerate ciliary beating (Shaari et al., 2006; Chen et al., 2007; Zhao et al., 2012; Workman and Cohen, 2014). In addition to their role in MCC, ciliated epithelial cells further function in innate immunity as the source of antimicrobial compounds including β-defensins, lysozyme, lactoferrin, and reactive oxygen species and also recruit the adaptive immune system through cytokine release (Parker and Prince, 2011; Waterer, 2012; Lee et al., 2014).
Initiation of this robust innate and adaptive immune response is coordinated through recognition of microbial products by a variety of receptors. Toll-like receptors (TLRs) are expressed on ciliated airway epithelial cells and recognize conserved bacterial structures called pathogen-associated molecular patterns (PAMPs). Well-known PAMPs include lipopolysaccharide, a major component of the outer membrane of gram-negative bacteria, lipoteichoic acid in gram-positive bacteria, and flagellin (Ooi et al., 2008). TLR activation generates a sustained immune response through changes in gene expression over a period of hours (Hume et al., 2001). Other defensive responses, such as the secretion of antimicrobial compounds and changes in ciliary beat frequency described above occur on a much more rapid timescale (Barham et al., 2013). This suggests that a subset of the upper airway immune response may be initiated through the detection of bacterial products through a non-TLR alternative mechanism.
Taste Receptors Regulate Upper Airway Immunity
Taste receptors are G-protein-coupled receptors that trigger a downstream signaling cascade in response to activation by a specific ligand (Zhang et al., 2003). Initially described in type II cells of the tongue and named for their role in taste (Margolskee, 2002), bitter (T2R) and sweet (T1R) taste receptors are also expressed in a variety of extra-oral tissues (Behrens and Meyerhof, 2010), including the sinonasal cavity (Lee et al., 2012, 2014) and respiratory tract (Shah et al., 2009), and have been recognized in recent years for their essential role in airway immune defense (Tizzano et al., 2010; Lee et al., 2012). More specifically, taste receptors in the upper airway have been described in both ciliated cells (Lee et al., 2012; Lee and Cohen, 2013) and the more rare solitary chemosensory cells (Braun et al., 2011; Barham et al., 2013; Lee et al., 2014; Figure 1).
Figure 1. Taste receptor function and downstream effects. In ciliated cells, stimulation of T2R38 and taste-receptor signaling results in activation of innate immune mechanisms including increased mucociliary clearance and nitric oxide release. In solitary chemosensory cells, stimulation of T2Rs results in a calcium-mediated release of antimicrobial peptides. This response is regulated by T1Rs such that under physiologic airway surface liquid glucose levels the T2R-mediated immune activation is inhibited. AMP, antimicrobial peptides; ASL, airway surface liquid; Ca2+, calcium ion; Gαgust, Gαgustducin; IP3, inositol trisphosphate; NO, nitric oxide; NOS, nitric oxide synthase; PLCβ2, phospholipase C isoform β2; T1R, sweet taste receptor; T2R, bitter taste receptor; TRPM5, transient receptor potential cation channel subfamily M member ion channel.
Bitter Taste Receptors in Ciliated Airway Cells
Initial support for the role of the T2R family of bitter taste receptors in upper airway immunity came from a 2009 study characterizing their expression and function in human bronchial ciliated epithelial cells. Researchers demonstrated that T2Rs located on motile cilia increased ciliary beating upon binding of known bitter agonists, establishing a role for cilia as “chemosensory organelles” and launching the hypothesis that T2Rs may detect noxious substances (Shah et al., 2009). However, ligands expected to be found in the airway with physiologic relevance had yet to be identified.
Further evidence for a role of taste receptors in airway immunity came from characterization of the T2R38 isoform in sinonasal ciliated epithelial cells and identification of bacterial acyl-homoserine lactones (AHLs). AHLs are quorum-sensing molecules produced by Pseudomonas aeruginosa and other gram negative bacteria and they serve as physiologic T2R38 ligands. Activation of T2R38 by two major P. aeruginosa AHLs results in a calcium-dependent increase in nitric oxide (NO) which is both directly bactericidal and also increases ciliary beat frequency and MCC (Lee et al., 2012). As many lactone compounds are bitter (Chadwick et al., 2013), it is logical to hypothesize that they may stimulate T2Rs. However, until Lee et al.'s initial T2R38 study, evidence of AHLs as physiologic ligands was limited to mouse studies. In those studies, stimulation of nasal solitary chemosensory cells (SCCs), which express both bitter and sweet taste receptors, caused a calcium-dependent release of acetylcholine and subsequent trigeminal activation that resulted in breath-holding and inflammatory mediator release (Finger et al., 2003; Tizzano et al., 2010, 2011; Saunders et al., 2014).
Recent research has expanded our understanding of the immune role of bitter taste receptors. T2R38 detection of AHLs has also been described in other cell types including human neutrophils (Maurer et al., 2015), and additional human pathogens such as Bacillus cereus have also been found to elicit a T2R-mediated NO response (Workman et al., 2017b). Building on the initial T2R38 studies, more recent studies in primary human sinonasal cultures demonstrated the ubiquitous expression of three other T2Rs, T2R4, and T2R14, T2R16, throughout the sinonasal tract with a similar ability to stimulate NO production in response to their respective ligands (Hariri et al., 2017b; Yan et al., 2017). Further studies are needed to determine the clinical relevance of these other T2R isoforms and their contributions to mucosal defenses.
T2R Bitter and T1R Sweet Receptors in Solitary Chemosensory Cells (SCCs)
Taste receptor expression in the upper airway is not limited to ciliated cells. Representing approximately 1 in 100 cells, SCCs are discrete non-ciliated cells that express both T2R bitter and T1R2/3 sweet taste receptors as well as other canonical taste signaling proteins (Finger et al., 2003; Tizzano et al., 2011; Barham et al., 2013). They were initially discovered in humans in the vomeronasal epithelium (Braun et al., 2011) and later throughout the sinonasal tract (Lee et al., 2014) at low density (Saunders et al., 2014). Preliminary studies in humans to elucidate SCC physiology with known bitter and sweet agonists found that these two modalities of taste work antagonistically to regulate the immune response. While T2R activation by bitter compounds initiated a traditional calcium taste-signaling cascade described in ciliated cells, T1R2/3 activation by glucose blocked this response (Lee et al., 2014). This regulation of bitter taste receptor signaling by the T1R sweet receptor suggests the ability to inhibit excessive immune activation during low levels of colonization and physiologic airway glucose concentration, and to release inhibition of the T2R-mediated immune response as glucose levels fall in early bacterial infection.
Notably, the downstream effects of T2R stimulation differ between cell types in the upper airway. In SCCs, T2R stimulation does not initiate NO secretion as in ciliated cells but rather propagation of the calcium signal results in rapid release of antimicrobial peptides from neighboring cells (Lee et al., 2014). This response occurs in minutes (Lee et al., 2014), providing support for taste receptors as early detectors of inhaled pathogens and activators of a more rapid immune response. While the T2R-initiated calcium cascade is similar across cell types in the human nasal cavity as well as consistent with earlier studies of SCCs in mice, its role in local immune regulation is distinct from that in ciliated airway cells and in contrast to the downstream effects of trigeminal activation seen in mice, suggesting possible adaptation in function or additional, yet unidentified triggers. Further studies are needed to characterize the role of SCCs and species differences in sinonasal physiology.
Taste Receptor Polymorphisms
Taste receptors display marked genetic diversity as evidenced by not only multiple receptor isoforms but also polymorphisms that modulate receptor function (Chandrashekar et al., 2000; Margolskee, 2002) with implications for taste, immunity, and consequently, disease. T2R and T1R polymorphisms correlate with bitter (Hayes et al., 2011) and sweet taste preferences (Mennella et al., 2005; Fushan et al., 2009; Bachmanov et al., 2014) as specific genotypes regulate receptor sensitivity, resulting in absent to intense taste perception of the same compounds between individuals (Bufe et al., 2005). Some of these same polymorphisms also correlate with severity of disease in CRS. Perhaps most well-studied are the polymorphisms in TAS2R38 that present as functional (PAV) and nonfunctional (AVI) T2R38 variants (Bufe et al., 2005). Compared with homozygotes for the functional allele, patients who are AVI/AVI homozygotes not only cannot taste bitter T2R38 agonists such as PTC but also show a decreased NO response to AHLs (Lee et al., 2012), increased susceptibility to gram-negative upper respiratory infections (Lee et al., 2012) and a higher burden of biofilm formation (Adappa et al., 2016b). Furthermore, AVI/AVI homozygotes with CRS are more likely to require surgical intervention (Adappa et al., 2013, 2014) and a subset of patients with CRS without nasal polyps may have worse outcomes after surgery (Adappa et al., 2016a). While less extensively studied, allele variations in TAS1R genes encoding sweet T1R receptors also show significant frequency differences between patients with CRS and controls (Mfuna Endam et al., 2014).
These findings suggest that genotypic variation results in phenotypic differences in both taste perception as well as airway disease. Current research in the field is focused on utilizing this relationship to assess taste receptor variation and function through simple taste tests. Preliminary studies have demonstrated phenotypic taste test differences between CRS and control patients to a variety of bitter and sweet compounds. Patients with CRS without nasal polyps were found to be less sensitive to the bitter compound denatonium while all CRS patients exhibited a hypersensitivity to sucrose (Workman et al., 2017a). This initial data supports phenotypic taste testing as a reflection of disease state. Given the clinical implications of the genotype-phenotype-disease correlation, taste testing to phenotypically assess a patient's taste receptor function and by extension susceptibility to disease or likelihood to benefit from certain treatments appears to be a promising future direction. Further studies are needed to clinically validate compounds and concentrations used to develop a taste test with predictive value.
Stimulators of Bitter and Sweet Taste Receptors and Potential Therapeutics
The previous studies discussed established the role of taste receptors as upper airway sensors capable of detecting bacteria and stimulating the innate immune response and offered the possibility that taste receptors may have utility as therapeutic targets. However, the genetic diversity of T2Rs and the high frequency of non-functional polymorphisms (Bufe et al., 2005; Lee et al., 2012) would limit their efficacy in this subset of patients. Recent studies have expanded our understanding of the wide range of biologically active compounds that can activate taste receptors and thus modulate upper airway immune defenses (Table 1). This has implications for both pathophysiology as well as treatment as we consider the question of whether pathogens may hijack these systems to circumvent immune detection as well as the possibility of novel therapeutics that could amplify the innate immune response.
Table 1. Taste receptor ligands in human sinonasal tissue.
Bitter T2R on Ciliated Cells Are Activated by Flavones
Many of the initial experiments characterizing T2R physiology used canonical bitter compounds that serve as ligands specific to the isoform being studied, for instance phenylthiocarbamide (PTC) activation of T2R38 (Kim and Drayna, 2005) and colchicine and D-Salicin for T2R4 and T2R16, respectively (Yan et al., 2017). The ability of T2Rs to detect bacteria and the chemical compounds they secrete was first described by the activation of T2R38 by AHLs produced by P. aeruginosa and the subsequent stimulation of immune mechanisms (Lee et al., 2014; Maurer et al., 2015; Gaida et al., 2016). T2R receptors are thus attractive therapeutic targets to amplify the natural host immune response.
While T2R agonists themselves, such as PTC, could serve as possible therapeutic agents, recent studies have shown promise for a number of biologically active compounds. Flavones, a class of flavonoids produced by plants previously noted to have antibacterial effects, also activate T2Rs (Roland et al., 2011; Kuroda et al., 2016). Studies of the effect of these compounds in the upper airway and on sinonasal pathogens demonstrated their ability to increase the efficacy of innate antimicrobials secreted by ciliated airway epithelial cells on P. aeruginosa (Hariri et al., 2017a) and induce NO production and increase MCC through activation of yet another T2R isoform (T2R14) (Hariri et al., 2017b). Identification of other receptor isoforms and the compounds to which they respond is therefore of particular clinical significance for their potential to activate endogenous immune defenses in individuals harboring a polymorphisms that renders T2R38 non-functional.
Sweet T1R on SCCs Are Activated by Glucose, D-Amino Acids
Sweet T1R receptors on SCCs have been shown to block immune activation until infection depletes airways surface liquid glucose concentrations, decreasing T1R signaling and releasing its inhibition of T2R-mediated immune responses. The data to support this is strong. Addition of both the bitter compound denatonium and the T1R2/3 agonists glucose and sucrose to sinonasal airway cultures showed inhibition of the T2R-mediated calcium cascade while cultures derived from mice that do not express the T1R2/3 receptors (Lemon and Margolskee, 2009) respond normally (Lee et al., 2014). Furthermore, researchers were able to block glucose/T1R-mediated downregulation of the SCC calcium cascade by using T1R2/3 antagonists such as lactisole (Jiang et al., 2005) and amiloride (Imada et al., 2010; Lee et al., 2014). This has implications not only for our understanding of CRS pathophysiology, as CRS patients have been noted to have chronically elevated ASL glucose (Lee et al., 2014) which may contribute to a cycle of weak immune defenses and chronic infection, but also for potential therapeutic targets.
Interestingly, bacteria may have found a way to co-opt this natural regulatory mechanism. Recent research has shown that D-amino acids produced by Staphylococcus species are capable of activating SCC sweet taste receptors and inhibiting T2R-mediated signaling (Lee et al., 2017). While Staphylococcus species are frequent sinonasal colonizers, suggesting that this may be one mechanism that allows them to evade immune eradication, T1R antagonists could be useful therapies in Staphylococcus-driven infections. Pharmacologic suppression of this T1R downregulatory pathway could thus prove to be a useful adjunct in augmenting the immune response, both in patients who would not be expected to respond to bitter agonists, but also in infection with particular bacterial species that have hijacked this pathway to evade immune detection. However, D-amino acids also inhibited P. aeruginosa biofilm formation, suggesting that immune suppression allowing commensal bacterial growth may offer protection against more pathogenic bacterial strains. Further research is needed to clarify the nature of such bacterial-host interactions prior to moving forward with T1Rs as a therapeutic target.
Conclusions
There is significant evidence to support the function of taste receptors as regulators of upper airway immunity. Activation of these receptors results in immediate-onset immune activation, complementing the more sustained and slower response achieved by activation of traditional innate immunity pathways such as TLRs, or at times suppression of the innate immune response. A wide range of biologically active compounds that activate T1R and T2R receptors have recently been described, increasing our understanding of not only additional receptor isoforms but also how receptor function may contribute to the pathophysiology of CRS. These findings suggest that targeting T1R and T2R receptors may allow for augmentation of the airway immune response and identify novel therapeutic targets that would allow the future treatment of CRS to be tailored to an individual patient's receptor profile. While further testing is needed, simple taste tests to determine taste perception phenotypes, which have shown a correlation with taste receptor genotype, may be used to predict not only susceptibility to disease but also potential response to a variety of therapies, allowing for truly personalized treatment.
Author Contributions
VT performed the literature search and wrote the manuscript. All authors reviewed and approved of the final manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The reviewer RJ and handling Editor declared their shared affiliation.
References
Adappa, N. D., Farquhar, D., Palmer, J. N., Kennedy, D. W., Doghramji, L., Morris, S. A., et al. (2016a). TAS2R38 genotype predicts surgical outcome in nonpolypoid chronic rhinosinusitis. Int. Forum Allergy Rhinol. 6, 25–33. doi: 10.1002/alr.21666
Adappa, N. D., Howland, T. J., Palmer, J. N., Kennedy, D. W., Doghramji, L., Lysenko, A., et al. (2013). Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. Int. Forum Allergy Rhinol. 3, 184–187. doi: 10.1002/alr.21140
Adappa, N. D., Truesdale, C. M., Workman, A. D., Doghramji, L., Mansfield, C., Kennedy, D. W., et al. (2016b). Correlation of T2R38 taste phenotype and in vitro biofilm formation from nonpolypoid chronic rhinosinusitis patients. Int. Forum Allergy Rhinol. 6, 783–791. doi: 10.1002/alr.21803
Adappa, N. D., Zhang, Z., Palmer, J. N., Kennedy, D. W., Doghramji, L., Lysenko, A., et al. (2014). The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. Int. Forum Allergy Rhinol. 4, 3–7. doi: 10.1002/alr.21253
Antunes, M. B., Gudis, D. A., and Cohen, N. A. (2009). Epithelium, cilia, and mucus: their importance in chronic rhinosinusitis. Immunol. Allergy Clin. North Am. 29, 631–643. doi: 10.1016/j.iac.2009.07.004
Bachmanov, A. A., Bosak, N. P., Lin, C., Matsumoto, I., Ohmoto, M., Reed, D. R., et al. (2014). Genetics of taste receptors. Curr. Pharm. Des. 20, 2669–2683. doi: 10.2174/13816128113199990566
Barham, H. P., Cooper, S. E., Anderson, C. B., Tizzano, M., Kingdom, T. T., Finger, T. E., et al. (2013). Solitary chemosensory cells and bitter taste receptor signaling in human sinonasal mucosa. Int. Forum Allergy Rhinol. 3, 450–457. doi: 10.1002/alr.21149
Behrens, M., and Meyerhof, W. (2010). Oral and extraoral bitter taste receptors. Results Probl. Cell Differ. 52, 87–99. doi: 10.1007/978-3-642-14426-4_8
Bhattacharyya, N. (2011). Incremental health care utilization and expenditures for chronic Rhinosinusitis in the United States. Ann. Otol. Rhinol. Laryngol. 120, 423–427. doi: 10.1177/000348941112000701
Bhattacharyya, N., and Kepnes, L. J. (2008). Assessment of Trends in Antimicrobial Resistance in Chronic Rhinosinusitis. Ann. Otol. Rhinol. Laryngol. 117, 448–452. doi: 10.1177/000348940811700608
Braun, T., Mack, B., and Kramer, M. F. (2011). Solitary chemosensory cells in the respiratory and vomeronasal epithelium of the human nose: a pilot study. Rhinology 49, 507–512. doi: 10.4193/Rhino11.121
Bufe, B., Breslin, P. A., Kuhn, C., Reed, D. R., Tharp, C. D., Slack, J. P., et al. (2005). The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Curr. Biol. 15, 322–327. doi: 10.1016/j.cub.2005.01.047
Carey, R. M., Workman, A. D., Hatten, K. M., Siebert, A. P., Brooks, S. G., Chen, B., et al. (2017). Denatonium-induced sinonasal bacterial killing may play a role in chronic rhinosinusitis outcomes. Int. Forum Allergy Rhinol. 7, 699–704. doi: 10.1002/alr.21949
Chadwick, M., Trewin, H., Gawthrop, F., and Wagstaff, C. (2013). Sesquiterpenoids lactones: benefits to plants and people. Int. J. Mol. Sci. 14, 12780–12805. doi: 10.3390/ijms140612780
Chandrashekar, J., Mueller, K. L., Hoon, M. A., Adler, E., Feng, L., Guo, W., et al. (2000). T2Rs function as bitter taste receptors. Cell 100, 703–711. doi: 10.1016/S0092-8674(00)80706-0
Chen, B., Antunes, M. B., Claire, S. E., Palmer, J. N., Chiu, A. G., Kennedy, D. W., et al. (2007). Reversal of chronic rhinosinusitis-associated sinonasal ciliary dysfunction. Am. J. Rhinol. 21, 346–353. doi: 10.2500/ajr.2007.21.3029
Cohen, N. A. (2017). The genetics of the bitter taste receptor T2R38 in upper airway innate immunity and implications for chronic rhinosinusitis. Laryngoscope 127, 44–51. doi: 10.1002/lary.26198
Cohen, N. A., Widelitz, J. S., Chiu, A. G., Palmer, J. N., and Kennedy, D. W. (2006). Familial aggregation of sinonasal polyps correlates with severity of disease. Otolaryngol. Head Neck Surg. 134, 601–604. doi: 10.1016/j.otohns.2005.11.042
Finger, T. E., Bottger, B., Hansen, A., Anderson, K. T., Alimohammadi, H., and Silver, W. L. (2003). Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration. Proc. Natl. Acad. Sci. U.S.A. 100, 8981–8986. doi: 10.1073/pnas.1531172100
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., et al. (2012). EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50, 1–12. doi: 10.4193/Rhino50E2
Fushan, A. A., Simons, C. T., Slack, J. P., Manichaikul, A., and Drayna, D. (2009). Allelic polymorphism within the TAS1R3 promoter is associated with human taste sensitivity to sucrose. Curr. Biol. 19, 1288–1293. doi: 10.1016/j.cub.2009.06.015
Gaida, M. M., Dapunt, U., and Hänsch, G. M. (2016). Sensing developing biofilms: the bitter receptor T2R38 on myeloid cells. Pathog. Dis. 74:ftw004. doi: 10.1093/femspd/ftw004
Gliklich, R. E., and Metson, R. (1995). The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol. Head Neck Surg. 113, 104–109. doi: 10.1016/S0194-5998(95)70152-4
Hariri, B. M., McMahon, D. B., Chen, B., Adappa, N. D., Palmer, J. N., Kennedy, D. W., et al. (2017a). Plant flavones enhance antimicrobial activity of respiratory epithelial cell secretions against Pseudomonas aeruginosa. PLoS ONE 12:e0185203. doi: 10.1371/journal.pone.0185203
Hariri, B. M., McMahon, D. B., Chen, B., Freund, J. R., Mansfield, C. J., Doghramji, L. J., et al. (2017b). Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor. J. Biol. Chem. 292, 8484–8497. doi: 10.1074/jbc.M116.771949
Hayes, J. E., Wallace, M. R., Knopik, V. S., Herbstman, D. M., Bartoshuk, L. M., and Duffy, V. B. (2011). Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem. Sens. 36, 311–319. doi: 10.1093/chemse/bjq132
Hopkins, C., Gillett, S., Slack, R., Lund, V. J., and Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clin. Otolaryngol. 34, 447–454. doi: 10.1111/j.1749-4486.2009.01995.x
Hume, D. A., Underhill, D. M., Sweet, M. J., Ozinsky, A. O., Liew, F. Y., and Aderem, A. (2001). Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol. 2:11. doi: 10.1186/1471-2172-2-11
Imada, T., Misaka, T., Fujiwara, S., Okada, S., Fukuda, Y., and Abe, K. (2010). Amiloride reduces the sweet taste intensity by inhibiting the human sweet taste receptor. Biochem. Biophys. Res. Commun. 397, 220–225. doi: 10.1016/j.bbrc.2010.05.088
Jiang, P., Cui, M., Zhao, B., Liu, Z., Snyder, L. A., Benard, L. M., et al. (2005). Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste. J. Biol. Chem. 280, 15238–15246. doi: 10.1074/jbc.M414287200
Kim, U. K., and Drayna, D. (2005). Genetics of individual differences in bitter taste perception: lessons from the PTC gene. Clin. Genet. 67, 275–280. doi: 10.1111/j.1399-0004.2004.00361.x
Kuroda, Y., Ikeda, R., Yamazaki, T., Ito, K., Uda, K., Wakabayashi, K., et al. (2016). Activation of human bitter taste receptors by polymethoxylated flavonoids. Biosci. Biotechnol. Biochem. 80, 2014–2017. doi: 10.1080/09168451.2016.1184558
Lee, R. J., and Cohen, N. A. (2013). The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis. Am. J. Rhinol. Allergy 27, 283–286. doi: 10.2500/ajra.2013.27.3911
Lee, R. J., Hariri, B. M., McMahon, D. B., Chen, B., Doghramji, L., Adappa, N. D., et al. (2017). Bacterial d-amino acids suppress sinonasal innate immunity through sweet taste receptors in solitary chemosensory cells. Sci. Signal. 10:eaam7703. doi: 10.1126/scisignal.aam7703
Lee, R. J., Kofonow, J. M., Rosen, P. L., Siebert, A. P., Chen, B., Doghramji, L., et al. (2014). Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J. Clin. Invest. 124, 1393–1405. doi: 10.1172/JCI72094
Lee, R. J., Xiong, G., Kofonow, J. M., Chen, B., Lysenko, A., Jiang, P., et al. (2012). T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J. Clin. Invest. 122, 4145–4159. doi: 10.1172/JCI64240
Lemon, C. H., and Margolskee, R. F. (2009). Contribution of the T1r3 taste receptor to the response properties of central gustatory neurons. J. Neurophysiol. 101, 2459–2471. doi: 10.1152/jn.90892.2008
Liu, L., Shastry, S., Byan-Parker, S., Houser, G., K, K. C., Birket, S. E., et al. (2014). An autoregulatory mechanism governing mucociliary transport is sensitive to mucus load. Am. J. Respir. Cell Mol. Biol. 51, 485–493. doi: 10.1165/rcmb.2013-0499MA
Margolskee, R. F. (2002). Molecular mechanisms of bitter and sweet taste transduction. J. Biol. Chem. 277, 1–4. doi: 10.1074/jbc.R100054200
Maurer, S., Wabnitz, G. H., Kahle, N. A., Stegmaier, S., Prior, B., Giese, T., et al. (2015). Tasting pseudomonas aeruginosa biofilms: human neutrophils express the bitter receptor T2R38 as sensor for the quorum sensing molecule N-(3-Oxododecanoyl)-l-Homoserine Lactone. Front. Immunol. 6:369. doi: 10.3389/fimmu.2015.00369
Mennella, J. A., Pepino, M. Y., and Reed, D. R. (2005). Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics 115, e216–e222. doi: 10.1542/peds.2004-1582
Meyerhof, W., Batram, C., Kuhn, C., Brockhoff, A., Chudoba, E., Bufe, B., et al. (2010). The molecular receptive ranges of human TAS2R bitter taste receptors. Chem. Senses 35, 157–170. doi: 10.1093/chemse/bjp092
Mfuna Endam, L., Filali-Mouhim, A., Boisvert, P., Boulet, L. P., Bosse, Y., and Desrosiers, M. (2014). Genetic variations in taste receptors are associated with chronic rhinosinusitis: a replication study. Int. Forum Allergy Rhinol. 4, 200–206. doi: 10.1002/alr.21275
Ooi, E. H., Wormald, P. J., and Tan, L. W. (2008). Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am. J. Rhinol. 22, 13–19. doi: 10.2500/ajr.2008.22.3127
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., et al. (2016). International consensus statement on allergy and rhinology: rhinosinusitis. Int. Forum Allergy Rhinol. 6, S22–S209. doi: 10.1002/alr.21695
Parker, D., and Prince, A. (2011). Innate immunity in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 45, 189–201. doi: 10.1165/rcmb.2011-0011RT
Roland, W. S. U., Vincken, J.-P., Gouka, R. J., van Buren, L., Gruppen, H., and Smit, G. (2011). Soy isoflavones and other isoflavonoids activate the human bitter taste receptors hTAS2R14 and hTAS2R39. J. Agric. Food Chem. 59, 11764–11771. doi: 10.1021/jf202816u
Rudmik, L. (2017). Economics of chronic rhinosinusitis. Curr. Allergy Asthma Rep. 17:20. doi: 10.1007/s11882-017-0690-5
Saunders, C. J., Christensen, M., Finger, T. E., and Tizzano, M. (2014). Cholinergic neurotransmission links solitary chemosensory cells to nasal inflammation. Proc. Natl. Acad. Sci. U.S.A. 111, 6075–6080. doi: 10.1073/pnas.1402251111
Shaari, J., Palmer, J. N., Chiu, A. G., Judy, K. D., Cohen, A. S., Kennedy, D. W., et al. (2006). Regional analysis of sinonasal ciliary beat frequency. Am. J. Rhinol. 20, 150–154.
Shah, A. S., Ben-Shahar, Y., Moninger, T. O., Kline, J. N., and Welsh, M. J. (2009). Motile cilia of human airway epithelia are chemosensory. Science 325, 1131–1134. doi: 10.1126/science.1173869
Sleigh, M. A., Blake, J. R., and Liron, N. (1988). The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 137, 726–741. doi: 10.1164/ajrccm/137.3.726
Soler, Z. M., Wittenberg, E., Schlosser, R. J., Mace, J. C., and Smith, T. L. (2011). Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope 121, 2672–2678. doi: 10.1002/lary.21847
Tizzano, M., Cristofoletti, M., Sbarbati, A., and Finger, T. E. (2011). Expression of taste receptors in solitary chemosensory cells of rodent airways. BMC Pulm. Med. 11:3. doi: 10.1186/1471-2466-11-3
Tizzano, M., Gulbransen, B. D., Vandenbeuch, A., Clapp, T. R., Herman, J. P., Sibhatu, H. M., et al. (2010). Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc. Natl. Acad. Sci. U.S.A. 107, 3210–3215. doi: 10.1073/pnas.0911934107
Waterer, G. W. (2012). Airway defense mechanisms. Clin. Chest Med. 33, 199–209. doi: 10.1016/j.ccm.2012.03.003
Wiener, A., Shudler, M., Levit, A., and Niv, M. Y. (2012). BitterDB: a database of bitter compounds. Nucleic Acids Res. 40, D413–D419. doi: 10.1093/nar/gkr755
Workman, A. D., Brooks, S. G., Kohanski, M. A., Blasetti, M. T., Cowart, B. J., Mansfield, C., et al. (2017a). Bitter and sweet taste tests are reflective of disease status in chronic Rhinosinusitis. J. Allergy Clin. Immunol. Pract. 17, 2213–2198. doi: 10.1016/j.jaip.2017.09.014
Workman, A. D., Carey, R. M., Kohanski, M. A., Kennedy, D. W., Palmer, J. N., Adappa, N. D., et al. (2017b). Relative susceptibility of airway organisms to antimicrobial effects of nitric oxide. Int. Forum Allergy Rhinol. 7, 770–776. doi: 10.1002/alr.21966
Workman, A. D., and Cohen, N. A. (2014). The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium. Am. J. Rhinol. Allergy 28, 454–464. doi: 10.2500/ajra.2014.28.4092
Yan, C. H., Hahn, S., McMahon, D., Bonislawski, D., Kennedy, D. W., Adappa, N. D., et al. (2017). Nitric oxide production is stimulated by bitter taste receptors ubiquitously expressed in the sinonasal cavity. Am. J. Rhinol. Allergy 31, 85–92. doi: 10.2500/ajra.2017.31.4424
Zhang, Y., Hoon, M. A., Chandrashekar, J., Mueller, K. L., Cook, B., Wu, D., et al. (2003). Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell 112, 293–301. doi: 10.1016/S0092-8674(03)00071-0
Keywords: chronic rhinosinusitis, upper airway immunity, bitter taste receptors, sweet taste receptors, host-pathogen interactions
Citation: Triantafillou V, Workman AD, Kohanski MA and Cohen NA (2018) Taste Receptor Polymorphisms and Immune Response: A Review of Receptor Genotypic-Phenotypic Variations and Their Relevance to Chronic Rhinosinusitis. Front. Cell. Infect. Microbiol. 8:64. doi: 10.3389/fcimb.2018.00064
Received: 10 October 2017; Accepted: 21 February 2018;
Published: 07 March 2018.
Edited by:
Richard George Douglas, University of Auckland, New ZealandCopyright © 2018 Triantafillou, Workman, Kohanski and Cohen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Noam A. Cohen, Y29oZW5uQHVwaHMudXBlbm4uZWR1